Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees

The post Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees appeared first on 24/7 Wall St..

Joel Greenblatt’s Magic Formula, popularized in The Little Book That Beats the Market, ranks stocks on two factors: earnings yield (operating earnings divided by enterprise value) and return on capital (how efficiently a business converts invested dollars into profits). For retirement investors, Magic Formula scores are only the starting point. Income reliability, business durability, and volatility matter equally. A bargain-screened name can still be wrong for a retiree if cash flows swing with commodity cycles or if its multiple assumes growth that may not arrive.

Below is a countdown of three candidates, ranked from least to most appropriate for a retirement-focused portfolio.

3. Qualcomm: Quality at a Quality Price

Qualcomm (NASDAQ: QCOM) is the classic Magic Formula quality stock: high gross margins, high returns on equity, and a fortress licensing business. Trailing return on equity is near 36.1%, operating margin around 22.1%, and EV/EBITDA at 14.7. Q2 FY26 delivered non-GAAP EPS of $2.65 on revenue of $10.599 billion, with record Automotive revenue of $1.326 billion, up 38% year over year.

The retirement problem is volatility and yield. Shares fell 16.2% in the past week and 23.9% in the past month, with a beta of 1.596. The dividend yield is just 1.9%, and handset revenue contracted 13% last quarter on memory supply constraints and China exposure. A great business, but not a retiree’s anchor holding.

2. Valero Energy: Cash Machine, Cyclical Risk

Valero Energy (NYSE: VLO) is where the Magic Formula screen lights up brightest. A forward P/E of 9, EV/EBITDA of 8.7, and return on equity of 15.9% combine to signal strong earnings yield and respectable capital efficiency. Q1 2026 EPS hit $4.22 against a $3.16 consensus, refining margins expanded to $14.90 per barrel, and management returned $938 million to shareholders while raising the quarterly dividend 6% to $1.20.

Shares are up 89.4% over the past year. That run is the catch. Refiner earnings swing with crack spreads, the Brent-WTI differential expanded to $5.94 per barrel from $3.43 per barrel, and California exposure produced a $123 million West Coast loss last quarter. The 1.9% yield is well covered, but earnings are not predictable enough for a retiree’s largest position.

1. CVS Health: The Retiree’s Magic Formula Pick

CVS Health (NYSE: CVS) combines Aetna insurance, the Caremark PBM, and roughly 9,000 retail pharmacies into a defensive, recession-resistant cash-generating enterprise. Forward P/E is just 14, beta is 0.623, and the dividend yields 2.6% on an annualized payout of $2.66. The dividend has been paid quarterly for more than 27 years without interruption.

The turnaround is showing in the numbers. Q1 2026 adjusted EPS came in at $2.57 against a $2.21 estimate, the fourth straight beat, with operating income up 38.71% year over year and Aetna’s adjusted operating income surging 52.6% to $3.04 billion as the medical benefit ratio improved to 84.6%. Management raised full-year adjusted EPS guidance to $7.30 to $7.50 and operating cash flow guidance to at least $9.5 billion. CEO David Joyner described the company as serving “nearly 185 million people” with strong enterprise execution. Shares have climbed 53.1% over the past year to $104.34.

Risks remain: pharmacy reimbursement pressure, elevated medical cost trends, lingering legacy litigation, and a goodwill-heavy balance sheet from the Aetna deal that drags reported return on capital. Even with those headwinds, the combination of a defensive healthcare footprint, low-beta shares, a multi-decade dividend record, and a forward earnings yield in the low-to-mid teens is the cleanest fit for someone funding retirement withdrawals.

What This Means for Retirement Portfolios

The Magic Formula is a starting point, not a verdict. Qualcomm offers the best business quality but the thinnest yield and highest volatility. Valero offers the loudest cheapness signal and a generous, growing payout, yet its earnings ride the refining cycle. CVS Health pairs a reasonable multiple with a defensive franchise, an improving Aetna margin story, and a dividend that has weathered every market cycle since the late 1990s. For a retirement investor weighing these three through a Greenblatt lens, CVS best balances cheapness, quality, and the income reliability that funds a withdrawal plan.

The post Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees appeared first on 24/7 Wall St..